New $35 Co-Pay Now Available Through Eli Lilly Insulin Value Program in Response to COVID-19 Crisis

Some good news about our insulin.

In response to the crisis caused by COVID-19, Eli Lilly is introducing the Eli Lilly Insulin Value Program, allowing anyone with commercial insurance and those without insurance at all to fill their monthly prescription of Lilly insulin for $35. The program is effective today and covers most Lilly insulins including all Humalog® (insulin lispro injection 100 units/mL) formulations.  There is more information at this website.